Early research (Phase 1)Study completedNCT00157703What this trial is testingG207 Followed by Radiation Therapy in Malignant GliomaWho this might be right forMalignant Glioma MediGene 9
Early research (Phase 1)Ended earlyNCT00880061What this trial is testingAn Open Label Dose Escalation Safety Study of Convection-Enhanced Delivery of IL13-PE38QQR in Patients With Progressive Pediatric Diffuse Infiltrating Brainstem Glioma and Supratentorial High-grade GliomaWho this might be right forBrain NeoplasmGlioma National Institute of Neurological Disorders and Stroke (NINDS) 7
Early research (Phase 1)Study completedNCT02313272What this trial is testingHypofractionated Stereotactic Irradiation (HFSRT) With Pembrolizumab and Bevacizumab for Recurrent High Grade GliomasWho this might be right forMalignant Glioma H. Lee Moffitt Cancer Center and Research Institute 32
Testing effectiveness (Phase 2)Looking for participantsNCT07680439What this trial is testingIlluminate: A Clinical Study Evaluating CAR T Immune Cell Therapy (BCB-276) for Patients With Diffuse Intrinsic Pontine Glioma (DIPG).Who this might be right forDiffuse Intrinsic Pontine GliomaDIPGBrain Tumor+9 more BrainChild Bio, Inc 75
Not applicableStudy completedNCT00214175What this trial is testingDetermination of Fraction Size Equivalent Dose (FED) Levels for Intracranial Conformal Avoidance RadiotherapyWho this might be right forGliomaBrain Neoplasms University of Wisconsin, Madison 44
Not applicableStudy completedNCT04860934What this trial is testingDual Task Training On Children With Ataxia After Medulloblastoma ResectionWho this might be right forMedulloblastoma, ChildhoodChildhood Cancer Children's Cancer Hospital Egypt 57357 30
Early research (Phase 1)Study completedNCT00004028What this trial is testingCarmustine in Treating Patients With Recurrent Malignant GliomaWho this might be right forBrain and Central Nervous System Tumors National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT01806675What this trial is testing18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis TherapyWho this might be right forAdult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma+41 more Sanjiv Sam Gambhir 25
Early research (Phase 1)Ended earlyNCT01088763What this trial is testingGamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell LeukemiaWho this might be right forChildhood Atypical Teratoid/Rhabdoid TumorChildhood Central Nervous System ChoriocarcinomaChildhood Central Nervous System Germinoma+43 more National Cancer Institute (NCI) 129
Early research (Phase 1)Study completedNCT00031083What this trial is testingDose Escalation Study to Determine the Safety of IFN-Beta Gene Transfer in the Treatment of Grade III & Grade IV GliomasWho this might be right forGlioblastoma MultiformeAnaplastic AstrocytomaOligoastrocytoma, Mixed+1 more Biogen 12
Early research (Phase 1)Ended earlyNCT01009866What this trial is testingStudy of Immunotoxin, MR1-1Who this might be right forSupratentorial Malignant Brain Tumor Darell D. Bigner, MD, PhD 9
Testing effectiveness (Phase 2)Study completedNCT00720356What this trial is testingBevacizumab and Erlotinib After Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or GliosarcomaWho this might be right forBrain and Central Nervous System Tumors Northwestern University 115
Testing effectiveness (Phase 2)Study completedNCT00124657What this trial is testingErlotinib and Radiation Therapy in Treating Young Patients With Newly Diagnosed GliomaWho this might be right forBrain and Central Nervous System Tumors St. Jude Children's Research Hospital 62
Testing effectiveness (Phase 2)Looking for participantsNCT04977375What this trial is testingTrial of Anti-PD-1 Immunotherapy and Stereotactic Radiation in Patients With Recurrent GlioblastomaWho this might be right forGlioblastoma Multiforme Chirag G. Patil 10
Testing effectiveness (Phase 2)Study completedNCT00019422What this trial is testingLobradimil and Carboplatin in Treating Children With Brain TumorsWho this might be right forBrain and Central Nervous System Tumors National Cancer Institute (NCI)
Early research (Phase 1)Looking for participantsNCT07179328What this trial is testingFocused Ultrasound Blood-Brain Barrier Disruption for the Treatment of High-Grade Glioma in Patients Undergoing Standard ChemotherapyWho this might be right forGBMGlioblastoma Multiforme (GBM)Glioblastoma Multiforme of Brain+5 more Sunnybrook Health Sciences Centre 10
Early research (Phase 1)Study completedNCT02457845What this trial is testingHSV G207 Alone or With a Single Radiation Dose in Children With Progressive or Recurrent Supratentorial Brain TumorsWho this might be right forSupratentorial Neoplasms, MalignantMalignant GliomaGlioblastoma+4 more Gregory K. Friedman, MD 13
Large-scale testing (Phase 3)Study completedNCT00482677What this trial is testingRadiation Therapy With or Without Temozolomide in Treating Older Patients With Newly Diagnosed Glioblastoma MultiformeWho this might be right forBrain and Central Nervous System Tumors Canadian Cancer Trials Group 562
Testing effectiveness (Phase 2)Looking for participantsNCT07589257What this trial is testingVRT106 in Combination With Radiotherapy in Adult Patients With Diffuse Midline Glioma / Diffuse Intrinsic Pontine GliomaWho this might be right forDiffuse Midline Glioma, H3 K27M-MutantDiffuse Intrinsic Pontine Glioma Guangzhou Virotech Pharmaceutical Co., Ltd. 10
Testing effectiveness (Phase 2)Looking for participantsNCT03213002What this trial is testingOral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBMWho this might be right forGlioblastoma Multiforme (GBM)GlioblastomaGlioma of Brain+6 more Northwell Health 67